AMR Action Fund

United States
cb
Founded:2020
Firm Location:United States • Massachusetts • New York, New York • Cambridge, Massachusetts
Investor Firms That Co-Invest with AMR Action Fund
Mission BioCapitalALSA VenturesAdjuvant Capital
AMR Action Fund Team
Photo of Martin Heidecker, Investor at AMR Action Fund
Martin Heidecker
AMR Action Fund·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed)
to see your intro paths to Martin
Photo of Carly Levine, Analyst at AMR Action Fund
Carly Levine
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in Boston / New England (Other Lists), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed)
to see your intro paths to Carly
Photo of Sergei Petukhov, Managing Director at AMR Action Fund
Sergei Petukhov
AMR Action Fund·Managing Director
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Boston (MA)
Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Series A), Investors in BioTech (Seed), Investors in Pharmaceuticals (Series A), Investors in Pharmaceuticals (Seed), Investors in BioTech (Seed), Investors in BioTech (Series A), Investors in Boston / New England (Other Lists), Investors in New York City (Other Lists)
to see your intro paths to Sergei
Photo of Henry Skinner, Investor at AMR Action Fund
Henry Skinner
AMR Action Fund·Investor
Sweet spot: $1.5M
Range: $100K - $5.0M
Investors in Massachusetts
Investors in Pharmaceuticals (Seed), Investors in Pharmaceuticals (Series A), Investors in BioTech (Series A), Investors in BioTech (Seed)
to see your intro paths to Henry